1. What It Is (Mechanism of Action)

GHK-Cu is a naturally occurring tripeptide (glycyl-L-histidyl-L-lysine) chelated with copper (Cu2+). Discovered in human plasma in 1973 by Dr. Loren Pickart, it regulates gene expression involved in collagen synthesis, elastin formation, anti-inflammatory cytokine modulation, and antioxidant defenses.

2. Clinical Indications Under Study

Topical skin remodeling, wound healing, hair follicle enlargement, cosmetic anti-aging, and pulmonary fibrosis attenuation.

3. FDA Approval & Regulatory Status

Status:Cosmetic Ingredient (Not FDA Approved as an Injectable Drug)

Cosmetic Ingredient (Not FDA Approved as an Injectable Drug)

4. Human Clinical Evidence Summary

Numerous peer-reviewed dermatological studies support the topical efficacy of GHK-Cu for skin elasticity, fine line reduction, and photoprotection. However, there are no FDA-approved systemic or injectable human drug formulations for clinical indications.

5. Known Risks, Side Effects & Boxed Warnings

Topical formulations are generally well-tolerated with low irritancy. Systemic/injectable use carries risks of systemic copper toxicity (Wilson's disease exacerbation), local injection site pain, tissue necrosis, and severe photolytic copper dissociation if stored improperly.

7. Why Gray-Market "Research Chemical" Versions Are Risky

Injectable GHK-Cu sold online is vulnerable to copper photoreduction (Cu2+ turning to insoluble Cu+), resulting in severe tissue inflammation, sterility failure, and chemical instability.
Peptides Agora Intelligence Wire
Weekly Research Brief

Get Breaking GHK-Cu Clinical Trial Alerts

Receive verified FDA dockets, Phase 3 readouts, and independent HPLC lab audits directly from our medical journalism desk.

HPLC Purity Audits
Independent lab test readouts & endotoxin assays
FDA PCAC Advisory
503A / 503B compounding votes and legal dockets
Phase 2/3 Readouts
Incretin & repair peptide clinical trial data
Zero vendor sponsorship or commercial advertisingUnsubscribe anytime with one click

8. Questions to Ask a Licensed Clinician

If you are discussing this compound with your doctor or healthcare provider, consider bringing these evidence-based questions:

  • Q1: What is the safety profile of topical GHK-Cu formulations compared to off-label injectable preparations?
  • Q2: Are there interactions between copper peptide skincare and active retinoids or ascorbic acid?

9. Primary Peer-Reviewed Sources & Citations

  • [1] Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. PubMed / Source →
  • [2] Badenhorst T, et al. Delivery of the copper tripeptide (GHK-Cu) through human skin. Drug Dev Ind Pharm. 2016;42(8):1243-1250. PubMed / Source →